Indian Liver Disease Drugs Market size stood at USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period (2019-2028).
India has been witnessing a rise in liver disease cases. Sedentary lifestyle, increase in non-communicable disorders like hypertension, obesity, and diabetes, etc have led liver disease to become the 10th most common cause of death. Around 10 lakh patients of liver cirrhosis are newly diagnosed every year in India, Liver disease affects every one in 5 Indians. In north India, 97 per cent of liver transplants are Living Donor Liver transplants, whereas only 3 per cent are cadaver (after brain death) transplants. Increasing prevalence of diseases such as hepatitis and liver cancer is expected to support growth of the market over the forecast period. The increasing rates of geriatric population have resulted in rise of the incidences of liver diseases, which further escalating the demand of liver disease treatment market.
Liver diseases therapeutic market is growing due to factors like in geriatric population, increasing prevalence of liver disease, government initiative of providing vaccines and growing awareness, change in lifestyle related diseases, increase in consumption of alcohol and improper diet and increase in research and development activities by companies. Growing habit of alcohol consumption, unhealthy diets increased the reasons for liver damage. This has accelerated the growth of Liver Disease Market Industry. Non-alcohol fatty liver disease is expected to increase on high rate during the forecast period and this will expand the market size of liver disease treatment industry. Rising prevalence of acute and chronic liver diseases is one of the major factors expected to drive the market for liver disease diagnostics. The favorable reimbursement policies by various health insurance programs is accelerating the market for liver disease diagnostics in India.